JANX

Janux Therapeutics, Inc.

Healthcare · Biotechnology

$113.27 sample

-1.47 (-1.28%) 1D

Market cap

$238.7B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-15

Alerts

8

Price$113.27 +8.59% 3M daily closessample

118.31101.93

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 22INSInsider sell: 10% owner
Sep 15SEC10-Q filed
Sep 07INSInsider buy: Chief Financial Officer
Aug 28INSInsider buy: General Counsel
Aug 19INSInsider sell: 10% owner
Aug 12SECForm 144 filed
Aug 03INSInsider sell: Director
Jul 29INSInsider sell: Chief Financial Officer

Sign up to see the real JANX record →

Company facts

SEC EDGAR registration

Name: Janux Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +46sample, -100 to +100
Reporting currency: USD

Who is positioning in JANX

sample

Insiders: 34 insider transactions over 90 days, net selling, $78.2M
Congress: No member trades over 90 days
Institutions · 13F: 43 funds hold $5.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.5B +12.4% y/y

Q4 2024Q3 2026

Inventory$4.3B +9.8% y/y

Q4 2024Q3 2026

Accounts receivable$3.2B +4.7% y/y

Q4 2024Q3 2026

Total debt$8.9B +9.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $147.8B +4.0% 3M
Sample peer B: $177.8B +9.1% 3M
Sample peer C: $229.0B +10.5% 3M
Sample peer D: $59.2B +15.0% 3M
Sample peer E: $77.8B -12.9% 3M